This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Laboratory findings

Authoring team

  • erythrocytes:
    • moderate to severe, normochromic, normocytic anaemia
    • marked variations in cell size and shape
    • elongated, teardrop-shaped erythrocytes (poikilocytes)
    • nucleated red cells may be present

  • leukoerythroblastosis:
    • immature myeloid and erythroid cells

  • platelets:
    • the platelet count is variable
    • thrombocytopaenia develops as the disease progresses
    • giant platelets are common
    • fragments of megakaryocytes may be present

  • leukocytes:
    • the white cell count is variable, and may be massively elevated
    • a left shifted picture with few immature forms
    • basophils are common

  • bone marrow:
    • there is often a dry tap, requiring a trephine biopsy
    • in the early stages, the marrow is hypercellular with a marked increase in megakaryocytes
    • later, diffuse fibrosis obliterates normal myeloid elements

  • leukocyte alkaline phosphatase is elevated

  • erythropoiesis in spleen may be shown by Fe-59 scan

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.